Added to YB: 2025-10-23
Pitch date: 2025-10-21
PFE [bullish]
Pfizer Inc.
+12.1%
current return
Author Info
HatedMoats identifies hated moats. I buy companies when the market panics. Contrarian investor focused on quality, value & long-term growth. Sign up for the newsletter.
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$155.6B
Pitch Price
$23.96
Price Target
36.00 (+34%)
Dividend
6.28%
EV/EBITDA
7.90
P/E
20.13
EV/Sales
3.24
Sector
Pharmaceuticals
Category
value
Pfizer: Deep Dive Analysis
PFE (deep dive): Pharma giant trades 8x forward P/E, 7% dividend yield despite strong fundamentals. Patent cliff risks $18B revenue 2025-30 but pipeline+acquisitions (Seagen $43B, Metsera for GLP-1) target $25B+ replacement. FCF yield 9%, margins recovering to 30%+. DCF suggests $34-36 fair value vs $25 current.
Read full article (25 min)